Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0F7QP
|
|||
| Former ID |
DIB003252
|
|||
| Drug Name |
StarGen Stargardt's disease gene therapy
|
|||
| Indication | Stargardt disease [ICD-11: 9B70; ICD-10: H35.5] | Phase 1/2 | [1] | |
| Company |
Sanofi us
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01367444) Phase I/IIa Study of StarGen in Patients With Stargardt's Macular Degeneration. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.